LXEO: Proyeksi bathi mangsa ngarep Lexeo

Logo perusahaan publik Lexeo Therapeutics (LXEO)

Lexeo Therapeutics (LXEO) is in the early stages of drug discovery, meaning the asset's market value depends on scientific reports. The business's uniqueness is based on the modification of APOE4 genetics to combat heart pathologies and Alzheimer's. Patent protection for DNA delivery methods limits competitor access. The company's future profit trajectory reflects these factors, where represents the current metric.

Lexeo Therapeutics (LXEO): Bathi resik sing dikarepake saka 04.07.2022 nganti 16.11.2026

Rincian metrik keuangan lan pasar Lexeo Therapeutics Inc. (LXEO)

Pambiji fundamental perusahaan:Lexeo Therapeutics, LXEO
Produk merek Lexeo Therapeutics, Inc.

Conservative capital demands transparency regarding future cash flows to assess business resilience amid uncertainty. This indicator aggregates analyst consensus forecasts for net income, reflecting market expectations for asset monetization, which currently stands at . The growth potential of the expected business yield chart for Lexeo Therapeutics (LXEO) depends directly on the outcomes of LX1001 clinical trials and genetic developments in cardiology.

Pesaing Lexeo Therapeutics

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|Taysha - Penghasilan resik sing dikarepake|Bathi sing dikarepake uniQure NV|Prakiraan bathi resik MGTX (MeiraGTx PLC)|Bathi mangsa ngarep RGNX (regenxbio.com)|Solid Biosciences Inc. - Prakiraan bathi resik|Bathi sing dikarepake Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Bathi resik sing dikarepake|BNTC - Bathi sing dikarepake|Design Pharma - Bathi resik mangsa ngarep|RCKT (Rocket Pharmaceuticals Inc) - Bathi mangsa ngarep|4D Molecular Therapeutics (FDMT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Korro Bio Inc.|Prakiraan bathi resik EDIT (Editas Medicine)|Bathi sing dikarepake Silence Therapeutics Corp (SLN)|PRQR (ProQR) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CDXS (Codexis, Inc.)|Prakiraan bathi perusahaan sangamo.com (SGMO)|nautilus.bio - Proyeksi bathi mangsa ngarep|Metagenomi (MGX) - Bathi mangsa ngarep|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep